Induction with Either Alemtuzumab, r-ATG or Basilixima Associated with Similar Outcomes in Kidney Transplant Recipients on Rapid Steroid Withdrawal.

被引：0
|
作者：
Reddy, K. S. [3 ]
Nijim, S. [1 ]
Chakker, H. [1 ]
Hamawi, K. [1 ]
Williams, J. [2 ]
Moss, A. [3 ]
Mulligan, D. [3 ]
Heilman, R. [1 ]
机构：
[1] Mayo Clin, Dept Med, Phoenix, AZ USA
[2] Mayo Clin, Dept Pathol, Phoenix, AZ USA
[3] Mayo Clin, Dept Surg, Phoenix, AZ USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2011年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
1414
引用
收藏
页码：441 / 441
页数：1
相关论文
共 50 条
  • [31] Alemtuzumab Induction with Early Steroid Withdrawal: Assessment of Outcomes after Kidney Transplantation at a Single Center.
    Khamash, Hasan
    Gaston, Robert
    Julian, Bruce
    Kew, Clifton
    Kumar, Vineeta
    Prendergast, Mary
    Deierhoi, Mark
    Young, Carlton
    Goodman, Jeremy
    Cook, William
    Curtis, John
    Mannon, Roslyn
    Hanaway, Michael
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 506 - 506
  • [32] CMV Infection in Renal Transplant Recipients: Five Year Experience with Campath-1H Induction and Early Steroid Withdrawal.
    Abate, Mersema T.
    Triolo, Diane
    Nord, Edward P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 680 - 680
  • [33] Rapid steroid withdrawal in hepatitis C virus (HCV) positive kidney transplant recipients.
    Akalin, E
    Murphy, B
    Ames, S
    Sehgal, V
    Ames, S
    Bromberg, JS
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 913A - 913A
  • [34] Early Steroid Withdrawal in African American Deceased Donor Renal Transplant Recipients with Alemtuzumab Induction: Is Graft Loss on the Horizon?
    Lynn, R.
    Ravichandran, B.
    Sparkes, T.
    Haririan, A.
    Bromberg, J.
    Casale, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 359 - 359
  • [35] Outcomes of Acute Allograft Rejection Treatment with R Anti-Thymocyte Globulin (r-ATG) One Year Post Kidney Transplant
    Yaqub, M.
    Riaz, A.
    Mishler, D.
    Adebiyi, O.
    Taber, T.
    Sharfuddin, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 995 - 995
  • [36] Outcomes of older Black renal transplant recipients receiving basiliximab induction and early steroid withdrawal
    Bova, Sarah E.
    Sparkes, Tracy
    Garcia, Emily
    Szczepanik, Amanda
    Bromberg, Jonathan
    Haririan, Abdolreza
    Casale, Jillian
    CLINICAL TRANSPLANTATION, 2024, 38 (02)
  • [37] Patterns of acute rejection in kidney transplant recipients treated with alemtuzumab induction and steroid-free maintenance therapy
    Bingaman, Adam W.
    Palma-Vargas, Juan
    Ortiz, Jorge
    Foster, Preston
    Wright, Francis
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 321 - 321
  • [38] Clinical Outcomes of Kidney Transplant Recipients by Steroid Early Withdraw Protocol with Basiliximab Induction
    Takada, Y.
    Hotta, K.
    Iwami, D.
    Higuchi, H.
    Hirose, T.
    Sasaki, H.
    Shinohara, N.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 576 - 576
  • [39] Alemtuzumab Induction Is Associated With Equalization of Graft Outcomes Between Elderly and Nonelderly Kidney Transplant Recipients: A Single-Center Report
    DeLeonibus, Anthony
    Mitro, Graham
    Brooks, Joseph
    Rees, Michael
    Ortiz, Jorge
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2020, 18 (03) : 284 - 291
  • [40] Sirolimus (srl) versus Everolimus (evr) versus Mycophenolate (mpa) in Kidney Transplant Recipients Receiving Anti-thymocyte Globulin Induction (r-atg), Tacrolimus (tac), and Prednisone
    Tedesco Silva Junior, H.
    Felipe, C.
    Viana, L.
    Cristelli, M.
    Tenorio, N.
    Lima, V.
    Azevedo, V.
    Ficher, K.
    Rezende, J.
    Foresto, R.
    Nakamura, M.
    Dreige, Y.
    Taddeo, J.
    Zito, C.
    Medina, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 689 - 689
12345